Skip to main content

Trifecta Capital Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1962615 NORTHBROOK, IL

Position in NVO

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$192,527
+$44,939 QoQ
Shares Held
4,016
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,039
of 1,348 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $49,578,365 across 11 Drug Manufacturers - General names. NVO ranks #7 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
4,016 $192,527

All Filings in NVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $192,527 4,016
2026-03-31 $147,588 4,016
2025-12-31 $82,222 1,616
2025-09-30 $34,181 616
2025-06-30 $42,516 616
2025-03-31 $42,775 616
2024-12-31 $52,472 610
2024-09-30 $72,632 610
2024-06-30 $87,071 610
2024-03-31 $78,324 610
2023-12-31 $63,104 610
2023-09-30 $55,473 610
2023-06-30 $32,366 200
2023-03-31 $31,828 200